You are viewing: Rest Of Europe Structural Heart Devices Market analysis

The Rest Of Europe Structural Heart Devices Market was valued at $279.4 Million in 2024 and projected to reach to $433.3 Million by 2029, representing a compound annual growth rate of 9.2%. Rest Of Europe's structural heart devices market is positioned for sustained growth through 2029, driven by demographic pressures and healthcare modernization initiatives across the region.

Rest Of Europe Structural Heart Devices Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Rest Of Europe Structural Heart Devices Market Trends and Insights

  • Rest Of Europe represents a significant opportunity within the broader European healthcare landscape, driven by aging populations, increasing prevalence of structural heart conditions, and rising adoption of minimally invasive interventional procedures.
  • Rest Of Europe's market expansion reflects growing healthcare infrastructure investments and improved reimbursement policies across multiple countries in the region. Rest Of Europe is witnessing accelerated demand for transcatheter aortic valve replacement (TAVR), mitral valve repair devices, and left atrial appendage (LAA) closure systems.
  • Rest Of Europe's 9.2% compound annual growth rate underscores the region's commitment to advancing cardiac care and adopting innovative treatment modalities.
  • Rest Of Europe's market trajectory is supported by favorable demographic trends, increasing physician training in structural heart interventions, and expanding patient awareness of less invasive treatment alternatives compared to traditional open-heart surgery..

Key Market Statistics

  • CAGR (2024-2029) 9.2% CAGR
  • Market Size, 2024 ~USD 279.4 Million
  • Forecast, 2029 ~USD 433.3 Million
  • Country Rest Of Europe

Rest Of Europe Structural Heart Devices Market Overview

Market Valuation Growth :

Rest Of Europe's structural heart devices market is valued at USD 279.4 million in 2024, with a projected CAGR of 9.2% through 2029, reaching USD 433.3 million by forecast end.

Aging Population Driver :

Rest Of Europe faces significant demographic shifts with aging populations, increasing the prevalence of structural heart conditions and driving demand for innovative device solutions across the region.

Minimally Invasive Adoption :

Rising adoption of minimally invasive procedures across Rest Of Europe is accelerating market growth, as healthcare systems prioritize patient outcomes and reduced recovery times in structural heart interventions.

Regional Healthcare Investment :

Increased healthcare spending and modernization of cardiac care infrastructure in Rest Of Europe countries are creating favorable conditions for structural heart device market expansion and innovation.

Rest Of Europe Structural Heart Devices Market Dynamics

  • The aging population base continues to expand the patient pool requiring structural heart interventions, while healthcare providers increasingly adopt advanced minimally invasive technologies to improve clinical outcomes and reduce hospital stays. The market outlook remains positive as Rest Of Europe countries invest in upgrading cardiac care facilities and training healthcare professionals in advanced device implantation techniques.
  • Regulatory harmonization efforts and growing reimbursement support for innovative structural heart solutions are expected to further accelerate market penetration, making Rest Of Europe an increasingly attractive market for device manufacturers and healthcare investors..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • Rest Of Europe's structural heart devices market will grow from USD 279.4 million in 2024 to USD 433.3 million by 2029, representing a 9.2% CAGR.
    • Rest Of Europe is experiencing increased adoption of minimally invasive structural heart interventions, particularly TAVR and mitral valve repair technologies.
    • Rest Of Europe's aging demographic profile and improving reimbursement landscapes are primary catalysts driving market expansion across the region.
    • Rest Of Europe's competitive environment is intensifying as both established and emerging device manufacturers expand their regional presence and product portfolios.

    Structural Heart Devices Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment TAVR/TAVI PROCEDURES (Type)
    Forecast Period 2024-2029
    Growth Rate CAGR of 9.5% from 2024 to 2029
    Largest Segment HOSPITALS (End User)
    Market Size Base Year (Billions) ~USD 16.32 (2024)
    Revenue Forecast (Billions) ~USD 25.69 (2029)
    Segments Covered Procedure, Type, Product, End User, Accessories

    Rest Of Europe Structural Heart Devices Market Report Segmentation

    5 segment dimensions are covered across the global market.

    By Procedure

    • Repair Procedures
    • Replacement Procedures

    By Type

    • Annuloplasty
    • Biological Valves
    • Catheters
    • Closure Procedures
    • Guidewires
    • Mechanical Valves
    • Other Accessories
    • Savr Procedures
    • Sheaths
    • Surgical Heart Valves
    • Surgical Valves
    • Tavr/Tavi Procedures
    • Teer Procedures
    • Tmvr Procedures
    • Transcatheter Aortic Valve Replacement (Tavr)
    • Transcatheter Heart Valves
    • Transcatheter Mitral Valve Replacement (Tmvr)
    • Valvuloplasty

    By Product

    • Accessories
    • Annuloplasty Rings
    • Heart Valve Devices
    • Occluders, Closure Systems And Delivery Systems
    • Occluders, Closure Systems, And Delivery Systems

    By End User

    • Ambulatory Surgical Centers
    • Ambulatory Surgical Centres
    • Hospitals
    • Other Accessories
    • Other End Users
    • Other End Users (Cath Labs, Cardiac Centers )
    • Other End Users (Cath Labs, Cardiac Centers)
    • Other End Users (Cath Labs, Cardiac Centres)
    • Others End Users

    By Accessories

    • Catheters
    • Guidewires
    • Other Accessories
    • Sheaths

    Target Audience

    • Medical Device Manufacturers : Device companies need Rest Of Europe-specific market data to develop localized product strategies, identify distribution partnerships, and allocate R&D resources for regional market penetration.
    • Healthcare Investors & PE Firms : Investment professionals require detailed Rest Of Europe market forecasts and growth drivers to evaluate acquisition targets, assess portfolio company performance, and identify emerging investment opportunities.
    • Hospital & Healthcare Systems : Healthcare administrators need market intelligence on structural heart device trends in Rest Of Europe to inform procurement strategies, budget planning, and technology adoption decisions.
    • Market Research & Consulting Firms : Research organizations require granular Rest Of Europe market data to support client advisory services, competitive benchmarking, and strategic planning engagements across the cardiac device sector.
    • Regulatory & Policy Advisors : Regulatory professionals need Rest Of Europe-specific market insights to understand device adoption patterns, reimbursement trends, and policy implications for structural heart interventions in the region.

    Reasons to Buy this Report

    • Regional Market Sizing & Forecasts : Obtain precise market valuation data specific to Rest Of Europe, including 2024 baseline (USD 279.4M) and 2029 projections (USD 433.3M), enabling accurate business planning and investment decisions.
    • Growth Opportunity Identification : Understand the 9.2% CAGR trajectory and key growth drivers unique to Rest Of Europe, including aging demographics and minimally invasive procedure adoption, to identify high-potential market segments.
    • Competitive Landscape Intelligence : Gain insights into Rest Of Europe-specific competitive dynamics, market players, and positioning strategies to inform go-to-market approaches and partnership opportunities in the region.
    • Regulatory & Reimbursement Insights : Access Rest Of Europe-specific regulatory environment and reimbursement landscape analysis to navigate market entry strategies and optimize pricing models for structural heart devices.
    • Strategic Investment Guidance : Leverage comprehensive Rest Of Europe market analysis to support M&A decisions, product development priorities, and resource allocation for maximizing ROI in this high-growth European segment.

    Frequently asked questions

    What is the current market size of structural heart devices in Rest Of Europe?

    Rest Of Europe's structural heart devices market was valued at USD 279.4 million in 2024 and is expected to reach USD 433.3 million by 2029.

    What is the projected growth rate for Rest Of Europe's structural heart devices market?

    Rest Of Europe's structural heart devices market is projected to grow at a compound annual growth rate (CAGR) of 9.2% from 2024 to 2029.

    Which structural heart devices are most in demand in Rest Of Europe?

    Rest Of Europe is experiencing strong demand for transcatheter aortic valve replacement (TAVR) systems, mitral valve repair devices, and left atrial appendage (LAA) closure systems.

    What factors are driving growth in Rest Of Europe's structural heart devices market?

    Rest Of Europe's market growth is driven by an aging population, increasing prevalence of structural heart conditions, improved reimbursement policies, and rising adoption of minimally invasive procedures.

    How does Rest Of Europe's market growth compare to global trends?

    Rest Of Europe's 9.2% CAGR is slightly below the global average of 9.5%, reflecting regional variations in healthcare infrastructure, regulatory environments, and patient demographics.

    RESEARCH METHODOLOGY

    The study involved four major activities to estimate the current size of the Structural heart devices market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to to identify and collect information for the study of Structural heart devices market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    Extensive primary research was conducted after obtaining information regarding the Structural heart devices market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, product development/innovation teams, and related key executives from manufacturers; distributors operating in the Structural heart devices market.; and key opinion leaders.

    Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to technology, application, vertical, and region. Stakeholders from the demand side customers/end users who are using infection control products were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage and the future outlook of their business, which will affect the overall market.

    The following is a breakdown of the primary respondents:

    Structural Heart Devices Market

    Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.

    Note 2: Other primaries include sales managers, marketing managers, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue.

    As of 2023: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=< USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The research methodology used to estimate the size of the Structural heart devices market includes the following details.

    The market sizing of the market was undertaken from the global side.

    Country-level Analysis: The size of the Structural heart devices market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall Structural heart devices market was obtained from secondary data and validated by primary participants to arrive at the total Structural heart devices market. Primary participants further validated the numbers.

    Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:

    Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

    Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

    At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall Structural heart devices market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

    Global Structural heart dsevices market size : Top-Down and Bottom-Up Approach

    Structural Heart Devices Market

    Data Triangulation

    The market was split into several segments and subsegments after arriving at the overall market size—using the market size estimation processes. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Structural heart devices market.

    Market Definition

    Structural Heart devices are used to treat conditions such as aortic valve disease, mitral valve disease, atrial septal defect, ventricular septal defect, hypertrophic cardiomyopathy, and tricuspid and pulmonic valve disease. Structural heart devices can be used to close holes in the heart, open narrowed heart valves, or replace damaged valves.

    Stakeholders

    • Medical Device Manufacturers
    • Cardiologists
    • Interventional Cardiologist
    • Healthcare institutions (hospitals and outpatient clinics)
    • Distributors and suppliers
    • Research institutes
    • Health insurance payers
    • Market research and consulting firms

    Report Objectives

    • To define, describe, segment, and forecast the global Structural heart devices market by product, procedure, end user, and region.
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets1 concerning individual growth trends, prospects, and contributions to the overall Structural heart devices market.
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
    • To forecast the size of the Structural heart devices market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile key players in the global Structural heart devices market and comprehensively analyze their core competencies2 and market shares.
    • To track and analyze competitive developments such as acquisitions, expansions, partnerships, agreements, and collaborations; and product launches and approvals.
    • To benchmark players within the Structural heart devices market using the "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy.

    Get the Full Structural Heart Devices Market Report

    Full forecast, segment splits, and company analysis for all Structural Heart Devices Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status